Enhancement of reverse genetics-derived swine-origin H1N1 influenza virus seed vaccine growth by inclusion of indigenous polymerase PB1 protein

Virus Research

Volumn 147, Issue 1, 2010, Pages 145-148

  Wanitchang, Asawin ^a   Kramyu, Jarin ^a   Jongkaewwattana, Anan ^a  

^a NATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY   (Thailand)

Author keywords

Novel swine origin influenza virus; PB1; PB1 F2; Reverse genetics; Seed vaccine

Indexed keywords

INFLUENZA VACCINE; PROTEIN PB1; UNCLASSIFIED DRUG; VIRUS ENZYME; VIRUS POLYMERASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC TRANSFECTION; GROWTH RATE; INFLUENZA VIRUS A H1N1; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; SWINE; VACCINE PRODUCTION; VIRAL GENETICS; VIROGENESIS; VIRUS GENE; VIRUS STRAIN;

HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; REASSORTANT VIRUSES; VIRAL PROTEINS;

ORTHOMYXOVIRIDAE; SUIDAE;

EID: 71149091053     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2009.10.010     Document Type: Article

References (16)

1. Chang L.Y., Shih S.R., Shao P.L., Huang D.T., and Huang L.M. Novel swine-origin influenza virus A (H1N1): the first pandemic of the 21st century. J. Formos. Med. Assoc. 108 (2009) 526-532
2. Garten R.J., Davis C.T., Russell C.A., Shu B., Lindstrom S., Balish A., Sessions W.M., Xu X., Skepner E., Deyde V., Okomo-Adhiambo M., Gubareva L., Barnes J., Smith C.B., Emery S.L., Hillman M.J., Rivailler P., Smagala J., de Graaf M., Burke D.F., Fouchier R.A., Pappas C., Alpuche-Aranda C.M., Lopez-Gatell H., Olivera H., Lopez I., Myers C.A., Faix D., Blair P.J., Yu C., Keene K.M., Dotson Jr. P.D., Boxrud D., Sambol A.R., Abid S.H., St George K., Bannerman T., Moore A.L., Stringer D.J., Blevins P., Demmler-Harrison G.J., Ginsberg M., Kriner P., Waterman S., Smole S., Guevara H.F., Belongia E.A., Clark P.A., Beatrice S.T., Donis R., Katz J., Finelli L., Bridges C.B., Shaw M., Jernigan D.B., Uyeki T.M., Smith D.J., Klimov A.I., and Cox N.J. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325 (2009) 197-201
3. Glaxo Smith Kline, Pandemic (H1N1) 2009 Influenza Update. Available at: http://www.glaxosmithkline.ch/desktopdefault.aspx/tabid-2/13_read-1164/.
4. Hancock K., Veguilla V., Lu X., Zhong W., Butler E.N., Sun H., Liu F., Dong L., Devos J.R., Gargiullo P.M., Brammer T.L., Cox N.J., Tumpey T.M., and Katz J.M. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N. Engl. J. Med. 361 (2009) 10.1056/NEJMoa0906453
5. Hoffmann E., Krauss S., Perez D., Webby R., and Webster R.G. Eight-plasmid system for rapid generation of influenza virus vaccines. Vaccine 20 (2002) 3165-3170
6. Mazur I., Anhlan D., Mitzner D., Wixler L., Schubert U., and Ludwig S. The proapoptotic influenza A virus protein PB1-F2 regulates viral polymerase activity by interaction with the PB1 protein. Cell Microbiol. 10 (2008) 1140-1152
7. Neumann G., Noda T., and Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459 (2009) 931-939
8. Potier M., Mameli L., Belisle M., Dallaire L., and Melancon S.B. Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate. Anal. Biochem. 94 (1979) 287-296
9. Smith G.J., Vijaykrishna D., Bahl J., Lycett S.J., Worobey M., Pybus O.G., Ma S.K., Cheung C.L., Raghwani J., Bhatt S., Peiris J.S., Guan Y., and Rambaut A. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 459 (2009) 1122-1125
10. Wang T.T., and Palese P. Unraveling the mystery of swine influenza virus. Cell 137 (2009) 983-985
11. Webby R.J., Perez D.R., Coleman J.S., Guan Y., Knight J.H., Govorkova E.A., McClain-Moss L.R., Peiris J.S., Rehg J.E., Tuomanen E.I., and Webster R.G. Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines. Lancet 363 (2004) 1099-1103
12. Webby R.J., and Sandbulte M.R. Influenza vaccines. Front. Biosci. 13 (2008) 4912-4924
13. World Health Organization. Availability of a candidate reassortant vaccine virus for the novel influenza A (H1N1) vaccine development X-179A. Available at: http://www.who.int/entity/csr/resources/publications/swineflu/2009_05_27_X179Aa.pdf.
14. Yongkiettrakul S., Boonyapakron K., Jongkaewwattana A., Wanitchang A., Leartsakulpanich U., Chitnumsub P., Eurwilaichitr L., and Yuthavong Y. Avian influenza A/H5N1 neuraminidase expressed in yeast with a functional head domain. J. Virol. Methods 156 (2009) 44-51
15. Zell R., Krumbholz A., Eitner A., Krieg R., Halbhuber K.J., and Wutzler P. Prevalence of PB1-F2 of influenza A viruses. J. Gen. Virol. 88 (2007) 536-546
16. Zhang, W., 2009. Candidate pandemic H1N1 vaccine viruses and vaccine potency reagents-an update of the development and availability. Available at: http://www.who.int/entity/immunization/sage/4.Zhang_SAGE_vaccine_virus_reagents_-_Final.pdf.